| Mary Jean Harford, MA, NCC | |
|
124 E Broad St Ste D, Falls Church, VA 22046-4530 | |
| (571) 310-2320 | |
| Not Available |
| Full Name | Mary Jean Harford |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 124 E Broad St Ste D, Falls Church, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033732771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 0704010304 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Jean Harford, MA, NCC 2418 N Dickerson St, Arlington, VA 22207-2668 Ph: (703) 338-1970 | Mary Jean Harford, MA, NCC 124 E Broad St Ste D, Falls Church, VA 22046-4530 Ph: (571) 310-2320 |
News Archive
Stressed individuals might be particularly prone to binge eating or drug addiction because of the high levels of the stress hormone corticotropin-releasing factor in their brain.
Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy. If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously.
Doctors can do a better job of diagnosing whooping cough among teens, an age group with a growing incidence of the illness, according to a University of Michigan study.
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful and joyful to them.
Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.
› Verified 4 days ago
Jessica Macnair, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2762 Marshall St, Falls Church, VA 22042 Phone: 571-335-0423 | |
Mrs. Bendu Elizabeth Jones, BA,CSAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-7788 Fax: 703-776-7798 | |
Alexandra Rose Dwight, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6565 Arlington Blvd Ste 405, Falls Church, VA 22042 Phone: 703-596-4796 | |
Ms. Ann Rayburn, ANN RAYBURN MA LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 313 Park Ave, Suite 300, Falls Church, VA 22046 Phone: 703-578-1065 | |
Callie Sapen, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 124 E Broad St Ste D, Falls Church, VA 22046 Phone: 703-534-5100 | |
Mrs. Amy Clay Stephens, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 124 E Broad St Ste D, Falls Church, VA 22046 Phone: 703-534-5100 |